Clinical Trials List
Protocol NumberCDAK539A12303
Not yet recruiting
2026-05-18 - 2032-05-31
Phase III
Not yet recruiting2
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- MING YAO 無
- HSIN-AN HOU 無
- - - 無
- YAO CHI-YUAN 無
- BANG-BIN CHEN 無
- - - 無
- 田豐銘 無
- Huai-Hsuan Huang 無
- 楊鎰聰 無
- 李婉瑄 無
- Wen-Chien Chou 無
- 袁章祖 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
13 participants
-
Global
460 participants
